SCHEMBL9723700

SCHEMBL9723700

COc1ccc(C2=C(c3ccccc3)C(=O)C(c3ccccc3)=C2c2ccc(OC)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.62
PDE4B Q07343 1/20 0.59
ME2 P23368 1/20 0.58
ME1 P48163 1/20 0.58
ME3 Q16798 1/20 0.58
MAPT P10636 4/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
TP53 P04637 1/20 0.57
TSHR P16473 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
NR1H2 P55055 1/20 0.54
NR1H3 Q13133 1/20 0.54
ALDH1A1 P00352 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
MITF O75030 1/20 0.52
HTT P42858 1/20 0.52
FGFR1 P11362 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13141855 1.00 BACE1 (0.62) BACE1PDE4BME2ME1ME3
SCHEMBL13585812 0.98 BACE1 (0.61) BACE1PDE4BME2ME1ME3
SCHEMBL13569202 0.98 BACE1 (0.61) BACE1PDE4BME2ME1ME3
SCHEMBL20299548 0.92 ME2 (0.67) BACE1ME2ME1ME3MAPT
SCHEMBL13642216 0.91 MEN1 (0.56) BACE1PDE4BME2ME1ME3
SCHEMBL10424199 0.89 ME2 (0.69) BACE1ME2ME1ME3MAPT
SCHEMBL13567262 0.88 BACE1 (0.51) BACE1PDE4BME2ME1ME3
SCHEMBL13119875 0.87 BACE1 (0.50) BACE1PDE4BME2ME1ME3
SCHEMBL2451792 0.83 GSTP1 (0.53) BACE1PDE4BMAPTTSHRSMN1; SMN2
SCHEMBL1063908 0.83 ME2 (0.86) BACE1PDE4BME2ME1ME3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774706-B1 IMPROVED PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS UNIV BOLOGNA ALMA MATER STUDIORUM (IT) 2023-12-20 EP claimed
EP-3774706-A1 IMPROVED PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS Alma Mater Studiorum Universita di Bologna (IT) 2021-02-17 EP claimed
WO-2019193079-A1 IMPROVED PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2019-10-10 WO claimed
WO-2025099082-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 2,5-DIHYDROXYMETHYLFURAN (BHMF) FROM 5-HYDROXYMETHYLFURFURAL (HMF) ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2025-05-15 WO disclosed
US-11932592-B2 Process for the transformation of primary aliphatic alcohols into higher aliphatic alcohols Alma Mater Studiorum—Universita' di Bologna (IT) 2024-03-19 US disclosed
EP-3558917-B1 NOVEL COMPOUND, SEMICONDUCTOR MATERIAL, AND METHODS FOR MANUFACTURING COATING AND SEMICONDUCTOR USING THE SAME MERCK PATENT GMBH (DE) 2024-01-24 EP disclosed
EP-3558917-B1 NOVEL COMPOUND, SEMICONDUCTOR MATERIAL, AND METHODS FOR MANUFACTURING COATING AND SEMICONDUCTOR USING THE SAME MERCK PATENT GMBH (DE) 2024-01-24 EP disclosed
EP-3774706-B1 IMPROVED PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS UNIV BOLOGNA ALMA MATER STUDIORUM (IT) 2023-12-20 EP disclosed
CN-110088072-B Novel compound, semiconductor material, film using same, and method for producing semiconductor 默克专利有限公司 2023-05-02 CN disclosed
US-11450805-B2 Compound, semiconductor material, and methods for manufacturing coating and semiconductor using the same MERCK PATENT GMBH (DE) 2022-09-20 US disclosed
US-20210163385-A1 PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2021-06-03 US disclosed
US-20200044158-A1 NOVEL COMPOUND, SEMICONDUCTOR MATERIAL, AND METHODS FOR MANUFACTURING COATING AND SEMICONDUCTOR USING THE SAME MERCK PATENT GMBH (DE) 2020-02-06 US disclosed
US-20200044158-A1 NOVEL COMPOUND, SEMICONDUCTOR MATERIAL, AND METHODS FOR MANUFACTURING COATING AND SEMICONDUCTOR USING THE SAME MERCK PATENT GMBH (DE) 2020-02-06 US disclosed
EP-3558917-A1 NOVEL COMPOUND, SEMICONDUCTOR MATERIAL, AND METHODS FOR MANUFACTURING COATING AND SEMICONDUCTOR USING THE SAME Merck Patent GmbH (DE) 2019-10-30 EP disclosed
WO-2018115043-A1 NOVEL COMPOUND, SEMICONDUCTOR MATERIAL, AND METHODS FOR MANUFACTURING COATING AND SEMICONDUCTOR USING THE SAME MERCK PATENT GMBH (DE) 2018-06-28 WO disclosed
WO-2018115043-A1 NOVEL COMPOUND, SEMICONDUCTOR MATERIAL, AND METHODS FOR MANUFACTURING COATING AND SEMICONDUCTOR USING THE SAME MERCK PATENT GMBH (DE) 2018-06-28 WO disclosed
US-5175242-A PHENYLATED POLYIMIDES PREPARED FROM 3,6-DIARYLPYROMELLITIC DIANHYDRIDE AND AROMATIC DIAMINES THE UNIVERSITY OF AKRON (US) 1992-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11932592-B2 Process for the transformation of primary aliphatic alcohols into higher aliphatic alcohols ADH1A, ADH5, ADH1C BACE1 3087/4885PDE4B 3862/4885ME2 507/4885
US-11450805-B2 Compound, semiconductor material, and methods for manufacturing coating and semiconductor using the same TYR, CD99, SRM BACE1 726/4885PDE4B 4612/4885ME2 4762/4885
US-20200044158-A1 NOVEL COMPOUND, SEMICONDUCTOR MATERIAL, AND METHODS FOR MANUFACTURING COATING AND SEMICONDUCTOR USING THE SAME TYR, TRPA1, CD99 BACE1 814/4885PDE4B 4281/4885ME2 4807/4885
US-20210163385-A1 PROCESS FOR THE TRANSFORMATION OF PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS ADH1A, ADH5, ADH1C BACE1 3087/4885PDE4B 3862/4885ME2 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.